Curing method of concrete: (a) standard curing environment; (b) 5 °C curing and −3 °C curing environments. by YongHe Liu (20477123)

Relationship curves fitted by Bai model: (a) standard curing; (b) 5 °C curing; (c) −3 °C. by YongHe Liu (20477123)

Student ARAS-PD scores as a function of research purpose and species (1–5 scale)¹. by Eric P. Sandgren (7542725)

Table_1_V241F KCNQ1 Mutation Shortens Electrical Wavelength and Reduces Ventricular Pumping Capabilities: A Simulation Study With an Electro-Mechanical Model.docx by Aulia Khamas Heikhmakhtiar (6093920)

“…We simulated three conditions; wild-type (WT), heterozygous/intermediate V241F, and pure V241F conditions in an electrophysiological single cell model and three-dimensional electro-mechanics ventricular model. …”

Table_5_Peach Fruit Development: A Comparative Proteomic Study Between Endocarp and Mesocarp at Very Early Stages Underpins the Main Differential Biochemical Processes Between Thes... by Carlos E. Rodriguez (3615815)

Data_Sheet_1_DNA Methylation Can Mediate Local Adaptation and Response to Climate Change in the Clonal Plant Fragaria vesca: Evidence From a European-Scale Reciprocal Transplant Ex... by Iris Sammarco (12158502)

“…Here, we assessed whether epigenetic mechanisms, DNA methylation in particular, enable for local adaptation and response to increased and/or decreased temperature of natural populations of a clonal plant, Fragaria vesca (wild strawberry). …”

Table 5_Ranges, temporal trend, and determinants of novel obesity indices in middle-aged and older Chinese population: insights from a nationally representative and longitudinal st... by Liufang Huang (12397954)

“…</p>Methods<p>Using data from the China Health and Retirement Longitudinal Study (CHARLS), we analyzed 17,708 adults in 2011 and followed 5,078 participants over 5 years nationally. …”

Table 5_A population-based analysis of the global burden of epilepsy across all age groups (1990–2021): utilizing the Global Burden of Disease 2021 data.xlsx by Ling-zhi Yang (20418434)

“…All of the ASPR, ASIR, ASMR and ASDR of males were higher than those of females, and the ASIR of epilepsy was the highest in children aged 0–14, at 61.00(95% UI: 39.09–86.21), while the older adult group aged 70+ has the highest ASMR of 5.67(95% UI: 4.76–6.18). From 1990 to 2021, the number of epilepsy-related deaths and DALYs both decreased. …”

Age at treatment initiation–cross sex hormones. by Lucy Thompson (3705940)

“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”

Study characteristics. by Lucy Thompson (3705940)

“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”

Age at treatment initiation–puberty suppression. by Lucy Thompson (3705940)

“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”

Search terms. by Lucy Thompson (3705940)

“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”

PRISMA diagram. by Lucy Thompson (3705940)

“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”

PRISMA 2020 checklist. by Lucy Thompson (3705940)

“…Puberty suppression (PS) was generally induced with Gonadotropin Releasing Hormone analogues (GnRHa), and at a pooled mean age of 14.5 (±1.0) years. Cross Sex Hormone (CSH) therapy was initiated at a pooled mean of 16.2 (±1.0) years. …”

Group 2 biomechanical testing of fractured limb callus at day 28 after fracture–Mechanical assessment of samples showed a higher twist angle and strain energy in the probiotic trea... by Yufa Wang (317537)

Table_2_Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case... by Qiang Ji (309652)

“…Moreover, CADM may necessitate earlier and more aggressive treatment strategies than CDM. Anti-MDA5 antibodies occur at a high level in patients with CADM, not only affecting the symptoms and prognosis of DM but also having a non-negligible impact on the differences between CADM and CDM. …”

Table_3_Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case... by Qiang Ji (309652)

“…Moreover, CADM may necessitate earlier and more aggressive treatment strategies than CDM. Anti-MDA5 antibodies occur at a high level in patients with CADM, not only affecting the symptoms and prognosis of DM but also having a non-negligible impact on the differences between CADM and CDM. …”

Table_1_Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case... by Qiang Ji (309652)

“…Moreover, CADM may necessitate earlier and more aggressive treatment strategies than CDM. Anti-MDA5 antibodies occur at a high level in patients with CADM, not only affecting the symptoms and prognosis of DM but also having a non-negligible impact on the differences between CADM and CDM. …”

Table_3_Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case... by Qiang Ji (309652)

“…Moreover, CADM may necessitate earlier and more aggressive treatment strategies than CDM. Anti-MDA5 antibodies occur at a high level in patients with CADM, not only affecting the symptoms and prognosis of DM but also having a non-negligible impact on the differences between CADM and CDM. …”

Table_1_Comparison of characteristics and anti-MDA5 antibody distribution and effect between clinically amyopathic dermatomyositis and classic dermatomyositis: a retrospective case... by Qiang Ji (309652)

“…Moreover, CADM may necessitate earlier and more aggressive treatment strategies than CDM. Anti-MDA5 antibodies occur at a high level in patients with CADM, not only affecting the symptoms and prognosis of DM but also having a non-negligible impact on the differences between CADM and CDM. …”